BRIEF-Surmodics receives IDE approval to initiate pivotal trial of the surveil™ drug-coated balloon By: Reuters: Company News July 26, 2017 at 08:20 AM EDT * Surmodics receives IDE approval to initiate pivotal trial of the surveil™ drug-coated balloon Read More >> Related Stocks: Surmodics Inc